Condition: Neoplastic Syndromes, Hereditary · Cancer · Genetic Predisposition to Disease · Sponsor: Sydney Children's Hospitals Network
Assessment of the utility of family-based (trio) whole-genome sequencing for cancer predisposition testing in sequential newly diagnosed paediatric and adolescent cancer patients
This description comes directly from the study's public registry record.
Clinical Trials Manager · +61 2 9382 3122 · SCHN-PREDICT@health.nsw.gov.au
Always discuss trial participation with your own doctor first.
| John Hunter Children's Hospital | Newcastle, New South Wales, Australia | Recruiting |
| Sydney Children's Hospital | Sydney, New South Wales, Australia | Recruiting |
| The Children's Hospital at Westmead | Sydney, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04903782